Skip to content

Tether Invests $200 Million in Neurotech Firm Blackrock: A Landmark Move in the Intersection of Stablecoins and Healthcare

In a groundbreaking move at the intersection of finance and healthcare, Tether, the company behind the world’s leading stablecoin, has announced a strategic investment of $200 million in Blackrock Neurotech. This investment marks a significant milestone for both Tether and Blackrock, as they collaborate to pioneer advancements in neurotechnology and medical solutions. Let’s delve deeper into the details of this landmark investment and its implications for the future of both stablecoins and healthcare technology.

Tether’s Investment in Blackrock Neurotech

On April 29, Tether revealed its strategic investment in Blackrock Neurotech, a renowned pioneer in human brain-computer-interface (BCI) technology. As part of this investment, Tether has become the majority stakeholder in Blackrock, signaling its commitment to driving innovation in the field of neurotechnology.

Blackrock Neurotech: A Leader in BCI Technology

Established in 2008, Blackrock Neurotech has been at the forefront of developing advanced brain-computer interfaces. These interfaces have the potential to revolutionize healthcare by assisting individuals suffering from paralysis, neurological disorders, and other debilitating conditions. Through its innovative technology, Blackrock Neurotech has enabled patients to regain control over their lives and perform everyday tasks using the power of their thoughts.

Applications of Blackrock Neurotech’s Technology

The impact of Blackrock Neurotech’s technology extends far beyond the realm of healthcare. Patients equipped with Blackrock’s brain interface have achieved remarkable feats, such as operating robotic arms, maneuvering wheelchairs, sending messages, surfing the internet, and even driving a car—all through the power of their minds. Notably, a Blackrock Neurotech patient made headlines in 2016 by using their brain-computer interface to interact with former U.S. President Barack Obama.

Tether’s Vision for the Future

Tether’s investment in Blackrock Neurotech represents a strategic move into the realm of healthcare technology through its newly established division, Tether Evo. Paolo Ardoino, CEO of Tether, expressed his excitement about the partnership, emphasizing Tether’s commitment to supporting projects that push the boundaries of technological innovation and human potential. Ardoino believes that Blackrock Neurotech is just the beginning of Tether’s journey in advancing the intersection of technology and human experience.

The Long-Term Impact

With Tether’s substantial investment, Blackrock Neurotech aims to accelerate the commercialization of its medical solutions and expand its research and development efforts. The ultimate goal is to provide life-changing advancements to millions of individuals worldwide, enhancing their quality of life and opening new frontiers in healthcare technology. Florian Solzbacher, co-founder of Blackrock Neurotech, expressed gratitude for Tether’s partnership, highlighting the shared vision of leveraging technology for the betterment of humanity.

Tether’s Diversification Strategy

The investment in Blackrock Neurotech comes on the heels of Tether’s recent announcement of four new business divisions, signaling its intent to diversify its operations beyond traditional stablecoin services. These divisions, including Tether Data, Tether Finance, Tether Power, and Tether Edu, underscore Tether’s commitment to exploring new avenues of growth and innovation.


Tether’s investment in Blackrock Neurotech represents a bold step into the realm of healthcare technology, showcasing the company’s vision for the future of stablecoins and beyond. By partnering with a leader in neurotechnology, Tether aims to catalyze advancements that will not only benefit individuals with neurological conditions but also drive progress at the intersection of technology and human potential. As Tether continues to expand its horizons and explore new frontiers, the collaboration with Blackrock Neurotech serves as a testament to the transformative power of innovation and collaboration in shaping a better future for all.